We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Multichannel Pipette Facilitates High-Throughput RNA Isolation

By LabMedica International staff writers
Posted on 13 Jun 2013
Print article
A new advanced multichannel pipette facilitates procedures such as a solid phase extraction-microplate method for reproducible, high throughput isolation of high quality, DNA-free total RNA.

Integra Biosciences (Zizers, Switzerland and Hudson, NH, USA) introduces the use of its new VIAFLO 384 electronic 384-channel pipette for procedures such as the high throughput isolation of total RNA. VIAFLO 384, an advanced version of Integra’s VIAFLO 96, is capable of both 96- and 384-channel pipetting via interchangeable heads, offering the benefits of an increased sample throughput option as well as lower sample and reagent use without the high expense of investing in a robotic liquid handling system. Designed to be used like a standard handheld pipette, the VIAFLO 384 requires no specialized skills or training for operation. It is also benchtop sized and can fit into laminar flow hoods.

VIAFLO 384 (and VIAFLO 96) is hand guided but movements are assisted by motors, enabling effortless and precise workflow. Pushing in one direction steers the pipetting head, making VIAFLO 384/96 intuitive to operate and freeing staff from training time. The VIAFLO 384 also features Integra’s popular “Touch Wheel” pipette-user interface, enabling simple and fast programming of a wide range of pipetting modes, including repeat dispense, serial dilute, and mixing routines. Up to 10 predefined pipetting modes are available to minimize set up time; alternatively, personalized custom programs can be created to suit diverse application needs.


Large-scale gene expression screening projects require reliable high-throughput methods to isolate high quality RNA from a large number of samples. To meet this need, a growing number of 96-well format RNA isolation kits are commercially available and are typically compatible with commonly used 96-well plate vacuum manifolds enabling the RNA extraction procedure to be accelerated. The video shows the use of the VIAFLO 384 handheld electronic pipette in conjunction with vacuum manifold, 96-well solid phase extraction (SPE) microplate, and RNA isolation kit to reproducibly extract high quality total RNA from cells.


Related Links:
Integra Biosciences

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Amoebiasis Test
ELI.H.A Amoeba

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.